None of us shareholders actually know why JN did what he did - so to call his actions "rookie mistakes" is offensive. To err is human and there aren't many chances in a career you get to take a company from the OTC to the Nasdaq - so we can't expect perfection.
And I would be extremely surprised if any of the cash is used to buy shares - unless perhaps the Nasdaq listing becomes in jeopardy.
Of course "fluff PR's" are unlikely to influence the share performance too much - but a reasonable earnings report will.